Stay updated on Paltusotine for Acromegaly Treatment Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly Treatment Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly Treatment Clinical Trial page
- Check4 days agoChange DetectedThe record describes a completed Phase 2 study of paltusotine for acromegaly, including its design, eligibility criteria, outcomes, and 26 study locations. It also provides posted results, study dates, and protocol and analysis-plan documents.SummaryDifference54%

- Check11 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH announcement about the website transition and updated AI/SI terminology was added, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to show a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now shows a 403 Forbidden error. The study record content is inaccessible, though site navigation remains visible.SummaryDifference17%

- Check60 days agoChange DetectedRevision indicator updated from v3.6.6 to v3.7.0 on the page, signaling a non-substantive update to the page template or CMS; no changes to the study data or eligibility criteria are reflected.SummaryDifference0.0%

Stay in the know with updates to Paltusotine for Acromegaly Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly Treatment Clinical Trial page.